Antibody responses and protection stimulated by sequential oral- parenteral immunization of mice with rotavirus

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 639-645

  McNeal, Monica M ^a   Rae, Mary N ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Antibody; Immunization; Rotavirus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION; VIRUS SHEDDING;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; FEMALE; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL VACCINES;

EID: 0033605224     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00244-8     Document Type: Article

References (41)

1. Kapikian A.Z., Chanock R.M. Rotaviruses. In: Fields B.N., Knipe D.M., editors. Fields Virology. 3rd edn. New York:Lippincott-Raven, 1996:1657-1708.
2. Institute of Medicine. Prospects for immunizing against rotavirus. In: New vaccine development. Establishing priorities. Diseases of importance in developing countries, Vol. II. National Academy Press, Washington, DC, 1986, pp. 308-318.
3. De-Mol P., Zissis G., Butzler J.P., Mutwewingabo A., Andre F.E. Failure of live, attenuated oral rotavirus vaccine. Lancet. ii:1986;108.
4. Christy C., Madore H.P., Pichichero M.E., Gala G., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 7:1988;645-650.
5. Bernstein D.I., Sander D.S., Smith V.E., Schiff G.M., Ward R.L. Protection from rotavirus reinfection: two-year prospective study. J. Infect. Dis. 164:1991;277-283.
6. Santosham M., Letson G.W., Wolff M., Reid R., Gahagan S., Adams R., Callahan C., Sack R.B., Kapikian A.Z. A field study of the safety and efficacy of two candidate vaccines in a Native American population. J. Infect. Dis. 163:1991;483-487.
7. Bernstein D.I., Glass R.I., Rodgers G., Sack D.A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. J. Am. Med. Assoc. 273:1995;1191-1196.
8. Clark H.F., White C.J., Offit P.A., Stinson D., Eiden J., Weaver S., Cho J., Shaw A., Krah D., Ellis R. Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine (QHBRV). Pediatr. Res. 37:1995;1016.
9. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T., Mack M.E., Davidson B.L., Kapikian A.Z. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the National Multicenter Trial. Pediatrics. 97:1996;7-13.
10. Lanata C.F., Midthun K., Black R.E., Butron B., Huapaya A., Penny M.E., Ventura G., Gil A., Jett-Goheen M., Davidson B.L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J. Infect. Dis. 174:1996;268-275.
11. Snodgrass D.R., Wells P.W. Rotavirus infection in lambs: studies on passive protection. Arch. Virol. 52:1976;201-205.
12. Offit P.A., Clark H.F. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:1985;58-64.
13. McNeal M.M., Sheridan J.F., Ward R.L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology. 191:1992;150-157.
14. Conner M.E., Crawford S.E., Barone C., Estes M.K. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67:1993;6633-6641.
15. Franco M.A., Greenberg H.B. Role of B cells and cytotoxic T lymphocytes in clearance of an immunity to rotavirus infection in mice. J. Virol. 69:1995;7800-7806.
16. McNeal M.M., Barone K.S., Rae M.N., Ward R.L. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology. 214:1995;387-397.
17. McNeal M.M., Broome R.L., Ward R.L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology. 204:1994;642-650.
18. Feng N., Burns J.W., Bracy L., Greenberg H.B. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:1994;7766-7773.
19. Svennerholm A.-M., Hanson L.A., Holmgren J., Lindblad B.S., Nilsson B., Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect. Immun. 30:1980;427-430.
20. Offit P.A., Cunningham S.L., Dudzik K.I. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J. Virol. 65:1991;1318-1324.
21. Coffin S.E., Moser C.A., Cohen S., Clark H.F., Offit P.A. Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. J. Virol. 71:1997;7851-7856.
22. McNeal M.M., Rae M.N., Conner M.E., Ward R.L. Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21. Virology. 243:1998;158-166.
23. Pierce N.F., Sack R.B., Sircar B.K. Immunity to experimental cholera: enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J. Infect. Dis. 135:1977;888-896.
24. Klipstein F.A., Engert R.F., Clements J.D. Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin. Infect. Immun. 37:1982;1086-1092.
25. Keren D.F., McDonald R.A., Carey J.L. Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri. Infect. Immun. 56:1988;910-915.
26. Hartman A.B., Van de Verg L.L., Collins H.H. Jr., Tang D.B., Bendiuk N.O., Taylor D.N., Powell C.J. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. Infect. Immun. 62:1994;412-420.
27. Ward R.L., McNeal M.M., Sheridan J.F. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:1990;5070-5075.
28. Knowlton D.R., Spector D.M., Ward R.L. Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Meth. 33:1991;127-134.
29. Ward R.L., McNeal M.M., Sheridan J.F. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology. 188:1992;57-66.
30. Coffin S.E., Offit P.A. Induction of mucosal B-cell memory by intramuscular inoculation of mice with rotavirus. J. Virol. 72:1998;3479-3483.
31. Pierce N.F. Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats. Infect. Immun. 43:1984;341-346.
32. Hamilton S.R., Yardley J.H., Brown G.D. Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids. Infect. Immun. 24:1979;422-426.
33. Pierce N.F., Kostner F.T. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats. J. Immunol. 124:1980;307-311.
34. Forrest B.D., LaBrooy J.T., Dearlove C.E., Shearman D.J.C. Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a. Infect. Immun. 60:1992;465-471.
35. McNeal M.M., Ward R.L. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology. 211:1995;474-480.
36. + T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J. Virol. 71:1997;479-486.
37. McNeal M.M., Rae M.N., Ward R.L. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J. Virol. 71:1997;8735-8742.
38. Moser C.A., Cookinham S., Coffin S.E., Clark H.F., Offit P.A. Relative importance of rotavirus-specific effector and memory B cells in protection against challenge. J. Virol. 72:1998;1108-1114.
39. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
40. Conley M.E., Delacroix D.L. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann. Int. Med. 106:1987;892-899.
41. McGhee J.R., Kiyono H. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 2:1993;55-73.